Weight Loss Drugs India
-
{
- All
- News
- Videos
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
Fake Weight Loss Drug Racket Busted In Gurugram, 2 Arrested
Authorities arrest two in Gurugram for making and selling fake Mounjaro injections.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Fake Weight Loss Injections Are Flooding The Market; Doctors Warn Patients Of Serious Health Risks
Fake weight loss injections are flooding the market, posing serious health risks. Dr Ravi Malik and Dr Shilpa Bhatte explain in depth about the prevalence of fake weight loss injections and how to safeguard yourself.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
Weight-Loss Drug Misuse Under Scanner, Centre Warns Of Legal Action For Violations
The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.
-
Semaglutide Weight-Loss Drugs May Help Prevent Deadly Heart Attack Complications
Popular weight-loss drugs like semaglutide may reduce life-threatening complications after heart attacks, a UK study finds. By improving blood flow in tiny vessels, these drugs could help the heart recover, but human trials are still needed.
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Safety Checks For New Generic Weight-Loss Drugs To Be Increased: Government
New Delhi, March 24 (IANS) Amid serious concerns over recent introduction of multiple generic variants of GLP-1 based weight loss drugs in the Indian market, the government on Tuesday said it has intensified regulatory surveillance against the drug’s
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
Fake Weight Loss Drug Racket Busted In Gurugram, 2 Arrested
Authorities arrest two in Gurugram for making and selling fake Mounjaro injections.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Fake Weight Loss Injections Are Flooding The Market; Doctors Warn Patients Of Serious Health Risks
Fake weight loss injections are flooding the market, posing serious health risks. Dr Ravi Malik and Dr Shilpa Bhatte explain in depth about the prevalence of fake weight loss injections and how to safeguard yourself.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
Weight-Loss Drug Misuse Under Scanner, Centre Warns Of Legal Action For Violations
The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.
-
Semaglutide Weight-Loss Drugs May Help Prevent Deadly Heart Attack Complications
Popular weight-loss drugs like semaglutide may reduce life-threatening complications after heart attacks, a UK study finds. By improving blood flow in tiny vessels, these drugs could help the heart recover, but human trials are still needed.
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Safety Checks For New Generic Weight-Loss Drugs To Be Increased: Government
New Delhi, March 24 (IANS) Amid serious concerns over recent introduction of multiple generic variants of GLP-1 based weight loss drugs in the Indian market, the government on Tuesday said it has intensified regulatory surveillance against the drug’s
